Magnesium supplementation and metabolic profiles in poly cystic ovary syndrome (pcos)
Phase 2
- Conditions
- polycystic ovary syndrome.Polycystic ovarian syndrome
- Registration Number
- IRCT201306161485N11
- Lead Sponsor
- Isfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 70
Inclusion Criteria
having poly cystic ovary syndrome according to the Rotterdam criteria; age between 20-45 years; not pregnant or lactating; non adherence to specific regime during the past 3 months; no smoking; no chronic diseases including, diabetes, cardio-vascular, liver, kidney, thyroid; non-food supplements; being overweight (BMI= 25 Kg/m2)
Exclusion criteria: hormone therapy; pregnancy and lactation during the study; weight loss (more than 2.5 kg per month) during the study
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum Insulin Level. Timepoint: Baseline, week 8. Method of measurement: Enzyme-Linked Immunosorbent Assay.
- Secondary Outcome Measures
Name Time Method